Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engerix-B multidose versus monodose immunogenicity study in healthy adults
2004-005262-20Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by GSK. Started Jul 2005; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2004-005262-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005262-20.